On Tuesday, Vaxart Inc (NASDAQ: VXRT) was -6.15% drop from the session before settling in for the closing price of $0.51. A 52-week range for VXRT has been $0.45 – $1.41.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 1372.05%. When this article was written, the company’s average yearly earnings per share was at -1.52%. With a float of $225.58 million, this company’s outstanding shares have now reached $227.77 million.
Let’s determine the extent of company efficiency that accounts for 115 employees. In terms of profitability, gross margin is 35.26%, operating margin of -230.99%, and the pretax margin is -232.36%.
Vaxart Inc (VXRT) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Vaxart Inc stocks. The insider ownership of Vaxart Inc is 1.04%, while institutional ownership is 22.43%. The most recent insider transaction that took place on Jun 18 ’24, was worth 13,578. In this transaction Director of this company bought 20,000 shares at a rate of $0.68, taking the stock ownership to the 78,125 shares.
Vaxart Inc (VXRT) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.1 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -1.52% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -12.51% during the next five years compared to 17.46% growth over the previous five years of trading.
Vaxart Inc (NASDAQ: VXRT) Trading Performance Indicators
You can see what Vaxart Inc (VXRT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.75. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.82.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.35, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -0.42 in one year’s time.
Technical Analysis of Vaxart Inc (VXRT)
Looking closely at Vaxart Inc (NASDAQ: VXRT), its last 5-days average volume was 1.84 million, which is a drop from its year-to-date volume of 1.93 million. As of the previous 9 days, the stock’s Stochastic %D was 30.53%. Additionally, its Average True Range was 0.05.
During the past 100 days, Vaxart Inc’s (VXRT) raw stochastic average was set at 5.87%, which indicates a significant decrease from 21.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 99.03% in the past 14 days, which was lower than the 101.81% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6351, while its 200-day Moving Average is $0.7070. However, in the short run, Vaxart Inc’s stock first resistance to watch stands at $0.5141. Second resistance stands at $0.5470. The third major resistance level sits at $0.5671. If the price goes on to break the first support level at $0.4611, it is likely to go to the next support level at $0.4410. Should the price break the second support level, the third support level stands at $0.4081.
Vaxart Inc (NASDAQ: VXRT) Key Stats
There are 227,949K outstanding shares of the company, which has a market capitalization of 109.67 million. As of now, sales total 28,700 K while income totals -66,950 K. Its latest quarter income was 15,190 K while its last quarter net income were -11,990 K.
